Insider Selling: Phreesia (NYSE:PHR) Insider Sells 3,761 Shares of Stock

Key Points

• Evan Roberts, an insider at Phreesia, Inc. (NYSE:PHR), sold 3,761 shares on September 16th for a total of $87,556.08, resulting in a 0.51% decrease in his position.
• Phreesia reported earnings of $0.01 per share for the quarter, outperforming analyst expectations of ($0.07), with revenue growth of 14.9% year-over-year.
• The stock has received a consensus rating of "Buy" from analysts, with a current price target estimated at $34.08.

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Evan Roberts sold 3,761 shares of Phreesia stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total value of $87,556.08. Following the transaction, the insider directly owned 726,837 shares in the company, valued at approximately $16,920,765.36. The trade was a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Evan Roberts also recently made the following trade(s):

• On Thursday, August 28th, Evan Roberts sold 3,400 shares of Phreesia stock. The shares were sold at an average price of $32.46, for a total value of $110,364.00.
• On Wednesday, August 27th, Evan Roberts sold 45,147 shares of Phreesia stock. The shares were sold at an average price of $32.02, for a total value of $1,445,606.94.
• On Thursday, July 17th, Evan Roberts sold 1,892 shares of Phreesia stock. The stock was sold at an average price of $26.89, for a total value of $50,875.88.

Phreesia Stock Down 1.3%

Shares of PHR stock traded down $0.32 during mid-day trading on Friday, hitting $23.87. The stock had a trading volume of 1,446,722 shares, compared to its average volume of 1,195,076. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $32.76. The firm has a market capitalization of $1.43 billion, a P/E ratio of -56.83 and a beta of 0.72. The firm's 50-day moving average is $27.57 and its two-hundred day moving average is $26.38. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.12 and a quick ratio of 2.12.

Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.08. The business had revenue of $117.26 million during the quarter, compared to analysts' expectations of $116.39 million. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The business's revenue for the quarter was up 14.9% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.03) EPS. Phreesia has set its FY 2026 guidance at EPS. On average, analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the topic of a number of recent research reports. Raymond James Financial set a $33.00 target price on Phreesia and gave the stock an "outperform" rating in a research note on Friday, September 5th. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. KeyCorp lifted their target price on Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. JMP Securities lifted their price objective on Phreesia from $30.00 to $34.00 and gave the company a "market outperform" rating in a report on Monday, September 8th. Finally, Needham & Company LLC upped their target price on Phreesia from $29.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating and twelve have given a Buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $34.08.

Institutional Investors Weigh In On Phreesia

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Squarepoint Ops LLC lifted its position in shares of Phreesia by 243.6% in the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company's stock worth $2,872,000 after purchasing an additional 71,553 shares during the period. Tower Research Capital LLC TRC grew its position in Phreesia by 332.5% during the second quarter. Tower Research Capital LLC TRC now owns 5,610 shares of the company's stock valued at $160,000 after buying an additional 4,313 shares during the period. State of Tennessee Department of Treasury bought a new position in Phreesia during the second quarter valued at about $330,000. BNP Paribas Financial Markets boosted its position in Phreesia by 128.2% during the second quarter. BNP Paribas Financial Markets now owns 12,284 shares of the company's stock worth $350,000 after purchasing an additional 6,902 shares during the period. Finally, Brevan Howard Capital Management LP boosted its position in Phreesia by 184.2% during the second quarter. Brevan Howard Capital Management LP now owns 31,418 shares of the company's stock worth $894,000 after purchasing an additional 20,363 shares during the period. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.